A New Epidemic: The Alarming Rise of GI Cancers in Young Adults
- Abigail Hahm
- Sep 12
- 5 min read
Updated: Sep 29
Gastrointestinal (GI) cancers, traditionally diagnosed in older adults, are now on the rise in populations previously considered low risk: adolescents and young adults. Most notably, colorectal cancer is emerging earlier and more aggressively in individuals as young as 15. Traditionally, GI cancers are detected in adults over the age of 45 through colonoscopies. According to the Centers for Disease Control and Prevention (CDC), the incidence of colorectal cancers in 15- to 19-year-olds has tripled in the last decade and doubled in those aged 20–24. The Yale School of Medicine reports that the rates of colorectal cancer rose from 8.6 per 100,000 to 12.9 between 1992 and 2018. Today, 10-12% of all colorectal cancers occur in young adults starting at age 20, and colorectal cancer has become the earliest GI cancer to make a presence, with rates rising by 2% annually since 2011.
Delayed Diagnoses and The Cost of Care
Despite these alarming trends and a lowered screening age (now 45, or as early as 35 for those with a family history), many younger patients experience delayed diagnoses. Symptoms like stomach aches, constipation, or fatigue are often dismissed by patients and providers alike as they resemble common, less serious conditions. Compounding the issue, young individuals often downplay their symptoms within a culture that glorifies the resilience and healthiness tied to being young. Providers, simultaneously, may overlook the warning signs in otherwise “healthy” patients, delaying critical treatment windows.
The financial burden of screening further exacerbates this issue. While colonoscopies are covered 100% under some insurances like Medicare, they can cost $400–$4,000 out of pocket for the uninsured or underinsured. This high cost is a significant barrier that prevents many from seeking timely screening, creating a serious health inequity.
Lifestyle, Environment, and Health Disparities
While genetics play a role, lifestyle and environmental factors are increasingly linked to early-onset colorectal cancer. Diets high in processed foods, added sugars, red meat, and preservatives, in combination with low fiber intake, contribute to poor gut health. The gut microbiome is crucial for immune and digestive function, so synthetic additives and low-nutrient foods negatively affect it. Environmental toxins, sedentary lifestyles, and rising obesity rates further drive one’s risk. Research shows that obesity significantly raises the risk of many diseases and health issues, specifically metabolic and GI-related cancers.
A study from the University of California, San Francisco (UCSF) found that certain regions, particularly the South—like the Mississippi Delta Region and the Appalachia—have the highest rates of colorectal cancer. States like Mississippi and Kentucky experience elevated mortality rates that are higher among men of Non-Hispanic Black, Non-Hispanic White, and Hispanic backgrounds. These regional patterns are often associated with limited healthcare access, higher poverty levels, and increased obesity rates.
The Impact on Research and Prevention
The momentum to understand and combat these early-onset cancers has slowed due to recent funding cuts and research pauses under President Trump’s administration. Cancer research is essential for progressing our understanding of preventative measures, but many trials and grants are stalled, limiting progress in prevention, diagnostics, and treatment innovations.
The rising rates demonstrate that a "healthy" lifestyle is not a complete shield. While an individual's personal risk may be lower, genetic predispositions and exposure to harmful toxins can still put them at risk. Furthermore, a full understanding of what constitutes a "healthy gut" remains elusive, a complex scientific challenge. Beyond the physical, a GI cancer diagnosis can cause significant anxiety, depression, and stress. It affects fertility and reproductive health in both men and women, underscoring why early detection and screening are important to the prevention and progression of these cancers.
A Call to Action
The rising rates of GI cancers in young adults are not just a medical issue but a reflection of a larger systemic failure. To address this epidemic, a multifaceted approach is needed. Continued investment in research is essential to understand the shifting cancer landscape and to develop next-generation diagnostics and therapies. Non-invasive screening alternatives must be developed to overcome the barriers of cost and invasiveness. Education efforts must be culturally competent and age-appropriate, targeting both younger individuals who downplay symptoms and providers who may overlook them.
Ultimately, America must reexamine its approach to public health, moving with urgency not just to treat illness but to prevent it. The systems we rely on - from food and healthcare to work culture and environmental policy - must be re-evaluated to ensure they work for, not against, the people they serve.
Read more about the impact of federal research funding cuts on the future of medicine and learn about the most anticipated drug launches of 2025.
Further Reading:
If you liked this article:
Share this article with your network on LinkedIn with your thoughts or perspectives. Make sure to tag us @HealthcareInsights to join the conversation.
Subscribe to our free newsletter, HealthcareIn Quicktakes. You'll never miss an article, and will get access to exclusive reports.
Check out our library of articles and reports on biotech, healthcare, policy, and business.
Who We Are: At Healthcare Insights, we're covering the transformation of healthcare and bringing our readers the most pertinent takes on key issues in medicine, biotech, healthcare policy, and business. Our Spotlight Series ✦ features thoughts from the most influential figures in healthcare, including Nobel Prize-winning scientists shaping tomorrow's treatments and business leaders bringing new therapies to market. We strive to publish coverage that is authentic, impartial, and independent of any financial or political motive. For more information regarding our editorial standards, read our statement. If you'd like to contact the Editor, use this form to get in touch.
If you'd like to stay in the loop, make sure to subscribe to our free newsletter, HealthcareIn Quicktakes, and follow us @healthcareinsights across our social channels, including LinkedIn.
©️ Copyright 2025 Healthcare Insights
All Rights Reserved
Legal Disclaimer:
The information provided in this article has been collected from various academic publications, industry reports/analyses, regulatory guidelines, media coverage, and legal analyses. The information provided is for general information purposes only and should not be construed for medical, legal, financial, or professional advice. Readers are advised to seek independent professional guidance where relevant. While we strive to ensure the accuracy and timeliness of our coverage, we claim no liability, representations, or warranties of any kind about the completeness, suitability, accuracy, reliability, authorship, or availability of this article and all pertaining data within this article. Neither the author nor the publication will assume liability for any loss or damage arising from the use of the information provided in the article. The information within this article may be outdated or inaccurate over time, and neither the author nor the publication are obligated to update or revise such information. We reserve the right to modify, remove, or substantially edit the article, including the disclaimer, at any time.
Comments